about
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysisPrevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.Adrenaline vs glucagon in the primacy of glucose counterregulation.Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitusCommentary on "Performance of a glucose meter with a built-in automated bolus calculator versus manual bolus calculation in insulin-using subjects".Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.Glucagon: the effects of its excess and deficiency on insulin action.Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetesPortal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans.Estimating plasma glucose from interstitial glucose: the issue of calibration algorithms in commercial continuous glucose monitoring devices.Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice.Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements.Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.Safety auxiliary feedback element for the artificial pancreas in type 1 diabetes.Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state.Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans.Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans.Adaptive calibration algorithm for plasma glucose estimation in continuous glucose monitoring.Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.A multiple local models approach to accuracy improvement in continuous glucose monitoring.Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover studyEffect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemiaPharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetesEvaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humansSuperiority of insulin analogues versus human insulin in the treatment of diabetes mellitusPlasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose ConcentrationStudy of abnormal adrenal receptors in subjects with ACTH-independent Cushing's syndrome and nodular adrenal hyperplasiaSeasonal Local Models for Glucose Prediction in Type 1 Diabetes
P50
Q33869737-77D44A1A-E168-44B0-BCC5-4A52B42ECF52Q34742884-7D47990E-AC21-43E6-A8D1-698496311C9DQ35080969-FE469393-FB14-4906-97BC-E91745279E59Q35563681-053F03C8-8402-4EF1-8304-CE3C544C8B00Q36051267-5907F1FF-6FA6-4A30-B564-536C72E78B6AQ36352480-9A4CDB86-983E-473C-8AAE-21EEE564D364Q36418460-CF14DEEB-DCBA-4B48-84A4-600275D56F82Q36426750-CDFC882C-F1E8-42E5-84A7-45A943B770FCQ37023046-CFC0BFDC-3C68-4487-8E13-EA759C561605Q37967765-EF3EB6BB-F0F6-48BB-B9FB-B8634681709AQ38176677-7F06A2A6-F8FE-4752-B2FA-16D17918EBDEQ40569379-6A1F1C74-E751-4663-94EB-C7790636A954Q42756051-2C27AB18-1FD3-42FD-881A-F0F9F8DF673EQ43942576-F1EE0AC5-426E-4BA7-8C16-3699B915B7C6Q43962449-2EB8E3B2-FA69-439A-A77E-B18068179EE2Q44362527-5648726B-CD41-4632-A6DF-6DD98B107FC3Q44418827-0B678AE7-DCBE-442F-9EE7-E9217D1A24A1Q44631824-956C0AA8-2890-4FA5-A31B-626A6D2A2A75Q45118534-BAF703F2-D309-4A34-AF2F-05BFCEC7F452Q45995941-F0F9C5F0-8B23-43B8-8328-0CEA407ADDA4Q46847419-50B67A42-B441-46FF-A61C-F039BE7D64A0Q46869958-FC7BE606-8D95-4DBA-82C0-E65F31F4F42DQ47794665-979087AD-615B-4292-B202-9E4172EF303FQ47865524-E27A471F-7EA3-4CEF-9D9A-4033FFEF0D91Q51537892-2E1D35E1-9827-452D-91EA-252A4308603BQ57951497-384438DF-B8F5-45E8-A333-DAD57986F9D8Q79424373-CC6C19BA-D8EF-4C22-9526-0DEB97D2CD04Q79782724-87F124CE-61F0-40CD-BC24-7EF84BB899D8Q79790489-18D1F4F1-4210-45B9-B73D-C2AECB4CD341Q81238500-C0C3586B-4948-48C9-8284-B8DCEC426515Q88327198-D0D47829-D4A3-42C0-B8AA-169AFDA83459Q91042644-C6B290F6-5BE0-405B-9CCA-23635B4F9E72Q91653864-975D80B6-12B4-4D81-967E-E570F9DB8E82
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Rossetti
@ast
Paolo Rossetti
@en
Paolo Rossetti
@es
Paolo Rossetti
@nl
Paolo Rossetti
@sl
type
label
Paolo Rossetti
@ast
Paolo Rossetti
@en
Paolo Rossetti
@es
Paolo Rossetti
@nl
Paolo Rossetti
@sl
prefLabel
Paolo Rossetti
@ast
Paolo Rossetti
@en
Paolo Rossetti
@es
Paolo Rossetti
@nl
Paolo Rossetti
@sl
P106
P21
P31
P496
0000-0002-2767-2996